A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice

Journal of the American Society of Nephrology

Volumn 25, Issue 1, 2014, Pages 119-128

  Cheung, Wai W ^a   Ding, Wei ^b   Gunta, Sujana S ^a   Gu, Yong ^b   Tabakman, Rinat ^c   Klapper, Leah N ^c   Gertler, Arieh ^d   Mak, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FUDAN UNIVERSITY   (China)

^c Bioline Innovations   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLOBULIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; PEGYLATED LEPTIN RECEPTOR ANTAGONIST; PEPTIDE HORMONE ANTAGONIST; PROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; APPETITE; ARTICLE; CACHEXIA; CALORIC INTAKE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENERGY EXPENDITURE; GASTROCNEMIUS MUSCLE; GRIP STRENGTH; HEPATIC INFLAMMATION; LIVER DISEASE; MOTOR COORDINATION; MOUSE; MUSCLE DEVELOPMENT; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; THERMOGENESIS; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 84891801868     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013040432     Document Type: Article

References (43)

1. Mak RH, Ikizler AT, Kovesdy CP, Raj DS, Stenvinkel P, Kalantar-Zadeh K: Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle 2: 9-25, 2011
2. Farooqi IS, O'Rahilly S: Leptin: A pivotal regulator of human energy homeostasis. Am J Clin Nutr 89: 980S-984S, 2009
3. Rayner DV, Trayhurn P: Regulation of leptin production: Sympathetic nervous system interactions. J MolMed (Berl) 79: 8-20, 2001
4. Mak RH, Cheung W: Adipokines and gut hormones in end-stage renal disease. Perit Dial Int 27[Suppl 2]: S298-S302, 2007
5. Axelsson J, Heimbürger O, Stenvinkel P: Adipose tissue and inflammation in chronic kidney disease. Contrib Nephrol 151: 165-174, 2006
6. Bjørbaek C, Kahn BB: Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59: 305-331, 2004
7. CheungW, Yu PX, Little BM, Cone RD,Marks DL,Mak RH: Role of leptin andmelanocortin signaling in uremia-associated cachexia. J Clin Invest 115: 1659-1665, 2005
8. Elinav E, Niv-Spector L, KatzM, Price TO, Ali M, YacobovitzM, Solomon G, Reicher S, Lynch JL, Halpern Z, Banks WA, Gertler A: Pegylated leptin antagonist is a potent orexigenic agent: Preparation and mechanism of activity. Endocrinology 150: 3083-3091, 2009
9. Elinav E, Ali M, Bruck R, Brazowski E, Phillips A, Shapira Y, Katz M, Solomon G, Halpern Z, Gertler A: Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function. Hepatology 49: 278-286, 2009
10. Shpilman M, Niv-Spector L, KatzM, Varol C, Solomon G, Ayalon-Soffer M, Boder E, Halpern Z, Elinav E, Gertler A: Development and characterization of high affinity leptins and leptin antagonists. J Biol Chem 286: 4429-4442, 2011
11. Peters JH, Simasko SM, Ritter RC: Leptin analog antagonizes leptin effects on food intake and body weight but mimics leptin-induced vagal afferent activation. Endocrinology 148: 2878-2885, 2007
12. Zhang J, Matheny MK, Tümer N, Mitchell MK, Scarpace PJ: Leptin antagonist reveals that the normalization of caloric intake and the thermic effect of food after high-fat feeding are leptin dependent.AmJ Physiol Regul Integr Comp Physiol 292: R868-R874, 2007
13. Ravussin E, Burnand B, Schutz Y, Jéquier E: Twenty-four-hour energy expenditure and resting metabolic rate in obese, moderately obese, and control subjects. Am J Clin Nutr 35: 566-573, 1982
14. Rubal A, Choshniak I, HaimA: Daily rhythms ofmetabolic rate and body temperature of two murids from extremely different habitats. Chronobiol Int 9: 341-349, 1992
15. Hsu CY, Chang FC, Ng HY, Kuo CC, Lee YT, Lu CY, Lee CT: Disrupted circadian rhythm in rats with nephrectomy-induced chronic kidney disease. Life Sci 91: 127-131, 2012
16. FukudaM,MizunoM, Yamanaka T,MotokawaM, Shirasawa Y,Nishio T, Miyagi S, Yoshida A, KimuraG: Patients with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension 52: 1155-1160, 2008
17. Rousset S, Alves-Guerra MC, Mozo J, Miroux B, Cassard-Doulcier AM, Bouillaud F, Ricquier D: The biology of mitochondrial uncoupling proteins. Diabetes 53[Suppl 1]: S130-S135, 2004
18. Cheung WW, Kuo HJ, Markison S, Chen C, Foster AC, Marks DL, Mak RH: Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice. J AmSoc Nephrol 18: 2517-2524, 2007
19. Park SW, Chen SWC, Kim M, Brown KM, Kolls JK, D'Agati VD, Lee HT: Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy. Lab Invest 91: 63-84, 2011
20. Avesani CM, Carrero JJ, Axelsson J, Qureshi AR, Lindholm B, Stenvinkel P: Inflammation and wasting in chronic kidney disease: Partners in crime. Kidney Int 70: S8-S13, 2006
21. Li W, Moylan JS, Chambers MA, Smith J, Reid MB: Interleukin-1 stimulates catabolism in C2C12 myotubes. Am J Physiol Cell Physiol 297: C706-C714, 2009
22. Baltgalvis KA, Berger FG, Peña MM, Davis JM, White JP, Carson JA: Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc (Min/+) mouse. Pflugers Arch 457: 989-1001, 2009
23. Fernández-Riejos P,Najib S, Santos-Alvarez J, Martín-Romero C, Pérez-Pérez A, González-Yanes C, Sánchez- Margalet V: Role of leptin in the activation of immune cells. Mediators Inflamm 2010: 568343, 2010
24. Guo S, Gonzalez-Perez RR: Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/ VEGFR-2 expression in breast cancer. PLoS One 6: e21467, 2011
25. Agrawal S,Gollapudi S, SuH,Gupta S: Leptin activates human B cells to secrete TNF-a, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. J Clin Immunol 31: 472-478, 2011
26. Mak RH, Rotwein P: Myostatin and insulin-like growth factors in uremic sarcopenia: The yin and yang in muscle mass regulation. Kidney Int 70: 410-412, 2006
27. Elliott B, Renshaw D, Getting S, Mackenzie R: The central role of myostatin in skeletal muscle and whole body homeostasis. Acta Physiol (Oxf) 205: 324-340, 2012
28. Zhang L, Rajan V, Lin E, Hu Z, Han HQ, Zhou X, Song Y, Min H,Wang X, Du J, Mitch WE: Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J 25: 1653-1663, 2011
29. Saxena NK, Taliaferro-Smith L, Knight BB, Merlin D, Anania FA, O'Regan RM, Sharma D: Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Res 68: 9712-9722, 2008
30. Ozbay T, Nahta R: A novel unidirectional cross-talk from the insulin-like growth factor-I receptor to leptin receptor in human breast cancer cells. Mol Cancer Res 6: 1052-1058, 2008
31. Sáinz N, Rodríguez A, Catalán V, Becerril S, Ramírez B, Gómez-Ambrosi J, Frühbeck G: Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice. PLoS One 4: e6808, 2009
32. Cheung WW, Mak RH: Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease. AmJ Physiol Renal Physiol 303: F1315-F1324, 2012
33. CheungWW,Rosengren S,Boyle DL,Mak RH:Modulation ofmelanocortin signaling ameliorates uremic cachexia. Kidney Int 74: 180-186, 2008
34. Hu J, Du J, Zhang L, Price SR, Klein JD, Wang XH: XIAP reducesmuscle proteolysis induced by CKD. J Am Soc Nephrol 21: 1174-1183, 2010
35. Zhang L, Ran L, Garcia GE, Wang XH, Han S, Du J, Mitch WE: Chemokine CXCL16 regulates neutrophil and macrophage infiltration into injured muscle, promoting muscle regeneration. Am J Pathol 175: 2518-2527, 2009
36. Shireman PK, Contreras-Shannon V, Ochoa O, Karia BP, Michalek JE, McManus LM: MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration. J Leukoc Biol 81: 775-785, 2007
37. Warren GL, Hulderman T, Mishra D, Gao X, Millecchia L, O'Farrell L, Kuziel WA, Simeonova PP: Chemokine receptor CCR2 involvement in skeletal muscle regeneration. FASEB J 19: 413-415, 2005
38. ToledoM, Busquets S, Ametller E, López-Soriano FJ, Argilés JM: Sirtuin 1 in skeletalmuscle of cachectic tumour-bearing rats: A role in impaired regeneration? J Cachexia Sarcopenia Muscle 2: 57-62, 2011
39. Wang YZ, Huang YN, Sun KY, Qi JH, Xiang L: Leptin gene transfer regulates fibromuscular development and lipid deposition in muscles via SIRT1, FOXO3a and PGC-1a in mice in vivo. Int JMolMed 28: 617-623, 2011
40. Barazzoni R, Zhu X, Deboer M, Datta R, CullerMD, ZanettiM, Guarnieri G, Marks DL: Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease. Kidney Int 77: 23-28, 2010
41. Wang YX, RudnickiMA: Satellite cells, the engines ofmuscle repair. Nat Rev Mol Cell Biol 13: 127-133, 2012
42. Armand AS, Bourajjaj M, Martínez-Martínez S, el Azzouzi H, da Costa Martins PA, Hatzis P, Seidler T, Redondo JM, De Windt LJ: Cooperative synergy betweenNFAT and MyoD regulatesmyogenin expression and myogenesis. J Biol Chem283: 29004-29010, 2008
43. Bohlen M, Cameron A, Metten P, Crabbe JC, Wahlsten D: Calibration of rotational acceleration for the rotarod test of rodent motor coordination. J Neurosci Methods 178: 10-14, 2009